Durable responses were seen when axicabtagene ciloleucel (axi-cel; Yescarta) was administered as a first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), according to findings ...
Sattva S. Neelapu, MD, professor and deputy department chair in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center, discusses ...
After 11 years of actively serving Loveland Ski Area, Zuma the avalanche dog died peacefully on Tuesday, May 28. According to a social media post made by the ski area on Wednesday, May 29, Zuma, 12, ...
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with axicabtagene ciloleucel (axi-cel), a chimeric antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback